Firms

Seven2

Paris, France · Milan, Italy · Amsterdam, Netherlands · Munich, Germany

Seven2 is the independent French private-equity manager legally Seven2 SAS, Paris RCS504829417, authorised by the AMF under GP08000057. Its origins date to1972; its French Apax Partners management company adopted the Seven2 name in an announcement expressly dated March16,2023, although the migrated page URL is dated September. It invests in growing European small and mid-market businesses, with technology, business services and healthcare investments including Porsolt preclinical research and AI-native Illuin Technology. Apax by Seven2 is its private-wealth brand and apax.fr is its associated French site. This Paris manager is distinct from London/global Apax Partners and Apax Digital at apax.com; their funds and existing investments are preserved separately. Thomas de Villeneuve became chairman and CEO effective July1,2025, succeeding Eddie Misrahi. Its current directory publishes79 named professionals; the September2026 appointment of Samuel de Bousquet adds an Evergreen leader outside that directory. Historical healthcare deal-team pages are qualified separately because current availability and affiliations can change. Own funds include institutional FPCIs, the retail evergreen Apeo FCPR and philanthropic vehicle; reported AUM and target fundraising are distinguished from actual funds raised. The October7,2026 own announcement confirms the final EUR314M close of Apax Development FundII, above FundI’s EUR255M, and its four investments including Illuin. MidMarketFundXI’s June2025 EUR1.6B target is not assigned as a completed close. Seven2’s majority acquisition of Porsolt was announced February21,2023; acquisition consideration and new cash paid to the company are undisclosed.

Founded: 1972
Type: Venture capital

Funds9

Apax Development Fund—€255M
Own table reports2018 FPCI and255MEURraised; October7,2026 finalFundIIclose primary corroborates predecessor255M. Exactlegalclose dayNULL.
Apax Development Fund II—€314M
OwnOctober7,2026 announcement confirms FINAL EUR314M close versusearlier350Mtarget. Launched2024 FPCI, actualclosingannouncementOct7 not guessedcashclosingday. Diapason/Olifan/SchoolOfArts/Illuin are fouractualcurrentinvestments.
Apax MidMarket IX—€1.03B
Own manager table reports2016 FPCI andEUR1.03B actualfundsraised; exactclosingdayNULL, distinctLondonApaxIXLP.
Apax MidMarket VIII—€701M
Own manager fund table reports FPCI launched2008 andEUR701M funds raised. Exactlegalclosingday unpublished; notLondonApaxVIII LP. Page stale2023heading conflictingnewentries notassumedcurrentdatestamp.
Apax Philanthropy Fund—€5M
Own table reports2022 evergreenFPCI EUR5Mraised. Perpetualphilanthropicstructure distinctprivateequityLPclose; exactmeasurement/closingdayNULL.
Apeo—€374M
Own table fundsraised EUR374M for2020evergreenFCPR; historical undisclosedmeasurementdate, notcurrent2026AUM orfixedclosedfund. September2026 ownrelease separatelyover600MAUM, NOTreplacementcashclose. DateNULL.
Seven2 Duality—€403M
Own manager table reports2025 FPCI EUR403M fundsraised, fiveyearstrategy. Exactclose dayNULL andstale2023headingnotassumed2023launch.
Seven2 MidMarket Fund XI——
OwnJune26,2025 CEOappointment release announcesfundraisinglaunch withEUR1.6B TARGET. Noindependentlyverifiedactualclosedsize asofOct8,2026; amount/dateNULL, no target/AUMascashclose.